Evaluating the effects of fluorine on biological properties and metabolic stability of some antitubulin 3-substituted 7-phenyl-pyrroloquinolinones.


Journal

European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510

Informations de publication

Date de publication:
15 Sep 2019
Historique:
received: 28 03 2019
revised: 31 05 2019
accepted: 31 05 2019
pubmed: 14 6 2019
medline: 3 10 2019
entrez: 14 6 2019
Statut: ppublish

Résumé

A small number of fluorinated 7-phenyl-pyrroloquinolinone (7-PPyQ) derivatives was synthesized in an attempt to improve the metabolic stability of 3N-ethyl-7-PPyQ and 3N-benzoyl-7-PPyQ. The possible impacts of the fluorine-hydrogen isosterism on both biological activity and metabolic stability were evaluated. Introduction of a fluorine atom in the 2 or 3 position of the 7-phenyl ring yielded the 7-PPyQ derivatives 12, 13 and 15, which showed potent cytotoxicity (low micromolar and sub-nanomolar GI

Identifiants

pubmed: 31195171
pii: S0223-5234(19)30516-1
doi: 10.1016/j.ejmech.2019.05.092
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Quinolones 0
Tubulin Modulators 0
Fluorine 284SYP0193

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

297-314

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

Roberta Bortolozzi (R)

Department of Woman's and Child's Health, University of Padova, Laboratory of Oncohematology, 35128, Padova, Italy.

Davide Carta (D)

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131, Padova, Italy.

Matteo Dal Prà (MD)

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131, Padova, Italy.

Giuseppe Antoniazzi (G)

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131, Padova, Italy.

Elena Mattiuzzo (E)

Department of Woman's and Child's Health, University of Padova, Laboratory of Oncohematology, 35128, Padova, Italy.

Mattia Sturlese (M)

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131, Padova, Italy.

Veronica Di Paolo (V)

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131, Padova, Italy.

Laura Calderan (L)

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131, Padova, Italy.

Stefano Moro (S)

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131, Padova, Italy.

Ernest Hamel (E)

Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, 21702, USA.

Luigi Quintieri (L)

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131, Padova, Italy.

Roberto Ronca (R)

Department of Molecular and Translational Medicine, Oncology and Immunology Section, University of Brescia, 29881, Brescia, Italy.

Giampietro Viola (G)

Department of Woman's and Child's Health, University of Padova, Laboratory of Oncohematology, 35128, Padova, Italy.

Maria Grazia Ferlin (MG)

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131, Padova, Italy. Electronic address: mariagrazia.ferlin@unipd.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH